Sarah Condella - 28 Feb 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
EVP, Human Resources
Signature
/s/ Sarah Condella by Mark Busch, attorney-in- fact
Issuer symbol
EXAS
Transactions as of
28 Feb 2025
Net transactions value
-$173,969
Form type
4
Filing time
04 Mar 2025, 16:37:41 UTC
Previous filing
26 Feb 2025
Next filing
30 Dec 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +3,780 +4.8% $0.000000 82,218 28 Feb 2025 Direct F1
transaction EXAS Common Stock Tax liability $84,976 -1,777 -2.2% $47.82 80,441 28 Feb 2025 Direct F2
transaction EXAS Common Stock Options Exercise $0 +3,958 +4.9% $0.000000 84,399 28 Feb 2025 Direct F1
transaction EXAS Common Stock Tax liability $88,993 -1,861 -2.2% $47.82 82,538 28 Feb 2025 Direct F2
transaction EXAS Common Stock Gift $0 -1,055 -1.3% $0.000000 81,483 03 Mar 2025 Direct F3, F4
holding EXAS Common Stock 6,100 28 Feb 2025 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -3,780 -33% $0.000000 7,560 28 Feb 2025 Common Stock 3,780 Direct F5, F6
transaction EXAS Restricted Stock Units Options Exercise $0 -3,958 -25% $0.000000 11,876 28 Feb 2025 Common Stock 3,958 Direct F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
F3 Represents a gift made pursuant to a Rule 10b5-1 Plan entered into on November 26, 2024.
F4 In addition to the shares of Common Stock reported on this Form 4, which total 87,583 shares, Ms. Condella also holds, in the aggregate, an additional 99,127 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F5 Each restricted stock unit represents a contingent right to receive one share of common stock.
F6 Represents a restricted stock unit award granted on February 24, 2023 that partially vested on February 28, 2025. The restricted stock units vest in four equal annual installments on the last trading day of February.
F7 Represents a restricted stock unit award granted on February 26, 2024 that partially vested on February 28, 2025. The restricted stock units vest in four equal annual installments on the last trading day of February.